Market Research Reports, Inc. has announced the addition of “PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Global Drug Forecast and Market Analysis to 2022” research report to their offering. See more at- http://mrr.cm/ZQP

1. www.MarketResearchReports.com
Category : Pharma & Healthcare
All logos and Images mentioned on this slide belong to their respective owners.

2. www.MarketResearchReports.com
Introduction to Report
 Launch Date: March 31, 2014
 Number of Pages: 188
 Geography Coverage: Global
 Available Format: PDF
Price For Single User License: USD 9,995
Price For Site License: USD 1,990
Price For Global User License: USD 29,985
Delivery Time: Within 24 Hours (During Working Days)

3. www.MarketResearchReports.com
About the Report
The first prophylactic vaccine for immunization against human
papillomavirus (HPV) became available in 2006. The global HPV
vaccines market is now well established, yet vaccine coverage
rates amongst the traditional target population of adolescent
girls remain persistently low. Initially HPV vaccines were
developed and marketed solely to protect against cervical
cancer.
In recent years the role of HPV in other cancers has been
increasingly recognized which has facilitated a shift towards
vaccinating a wider population, most significant has been the
inclusion of males in routine vaccine recommendations in some
countries. The current HPV vaccines market is dominated by one
major player, Merck’s Gardasil, with GlaxoSmithKline’s (GSK’s)
HPV vaccine Cervarix providing the only competition. The
introduction of Merck’s nine-valent vaccine (V503) is set to
change the future landscape of the HPV vaccines sector.

4. www.MarketResearchReports.com
Research Findings
Global Prophylactic Human Papillomavirus Vaccine Market to
Reach $2.2 Billion by 2022, but Access Barriers Must be
Overcome, says Publisher
The global prophylactic human papillomavirus (HPV) vaccine
market value is forecast to experience moderate growth over the
coming years, climbing from $1.7 billion in 2012 to $2.2 billion
by 2022, at a Compound Annual Growth Rate (CAGR) of 2.6%,
says a new report from research and consulting firm by
Publisher.
The company’s report states that out of the nine major markets
(9MM: the US, Canada, France, Germany, Italy, Spain, the UK,
Japan and Australia), HPV vaccine sales in Canada and Australia
are expected to grow at the largest CAGRs of over 9% during the
forecast period.
Publisher believes that Merck’s upcoming nine-valent pipeline
vaccine V503 is well placed to capitalize on this need, with sales
forecast to reach $1.5 billion in the US alone by 2022,
representing a massive 95% market share.

5. www.MarketResearchReports.com
Research Findings Continues..
New nine-valent HPV vaccines are expected to be widely
adopted following market approval, stealing market share from
existing vaccines. Though a high price represents a potential
barrier to market access.
Significant environmental barriers to HPV vaccination exist,
which currently serve to limit vaccine uptake.
The emphasis of HPV vaccination is shifting away from an initial
focus on cervical cancer prevention in females, towards
prevention of a range of cancers in both males and females.
The inclusion of males in routine HPV vaccine
recommendations will expand the size of the HPV vaccines
market

6. www.MarketResearchReports.com
Report Coverage
1. Introduction
2. Disease Overview
3. Vaccination Recommendations and Coverage Rates
4. Competitive Assessment
5. Unmet Need and Opportunity
6. Pipeline Assessment
7. Current and Future Players
8. Market Outlook
9. Appendix
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.

7. www.MarketResearchReports.com
Company Coverage
1. Merck
2. GSK
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.

8. www.MarketResearchReports.com
Custom Research:
 Are you an industry professional, entrepreneur,
venture capitalist, investors and organization, then let
us know your specific research requirements. Our goal
is to cater to your requirements be it for a custom
market research project, syndicated research report on
a specific market or industry sector, newsletter creation,
case study development or anything else related to
marketing research.
For Any Customization Related query Visit IdeaCenter @
http://www.marketresearchreports.com/idea-center

9. www.MarketResearchReports.com
How To Buy This Report?
Visit following URL to see Table of Content and
purchase this publication:
http://mrr.cm/ZQP
About Market Research Reports, Inc.
Market Research Reports provides a customized set
of reports from reputed Publishers, built on the
intelligence available within organizations and
leverages on our motto of “Intelligence Redefined”.
Contact : Amitava Sen
Email : info@marketresearchreports.com
Phone: +1 302-703-7787 (USA) +91-8762746600 (India)